Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. South Texas Botanicals
WARNING LETTER
•South Texas Botanicals•October 6, 2017

South Texas Botanicals – FDA Warning Letter, Oct 6, 2017

Record Details

On March 29, 2018, the FDA issued a Warning Letter to South Texas Botanicals following an inspection from September to October 2017. The inspection and subsequent review of product labels and a mail order catalog revealed serious violations of the Federal Food, Drug, and Cosmetic Act.

The FDA determined that several products, including Oral Health, LDMS Formula, and Diabetic Formula, were promoted with claims in the mail order catalog that established them as unapproved new drugs. These claims indicated intended use for the cure, mitigation, treatment, or prevention of disease, making them "new drugs" under Section 201(p) of the Act, requiring prior FDA approval. Additionally, some products were deemed misbranded under Section 502(f)(1) because they lacked adequate directions for use by a layperson, particularly those intended for conditions requiring professional supervision. This was a repeat observation from a January 2017 inspection, and the firm's response regarding ongoing labeling revisions was deemed inadequate.

Furthermore, all dietary supplements were found to be adulterated under Section 402(g)(1) due to non-compliance with Current Good Manufacturing Practice (CGMP) regulations (21 CFR Part 111). Specific CGMP violations included: 1. Failure to establish specifications for components and finished dietary supplements (21 CFR 111.70(a), (b)(1)-(3),

Company
South Texas Botanicals
Inspection date
October 6, 2017
Product type
Drugs
Office
Dallas District Office
People
  • Edmundo Garcia (Program Director)
  • Lori Woznicki (Director)
View Company Profile

ID · 2a5d128b-0b42-4abc-bd8f-58865533d882

Violation Codes10
21 CFR 11121 U.S.C. 343(q)(5)(F)21 CFR 111.26021 CFR 101.3621 U.S.C. 342(g)(1)21 CFR 111.21021 CFR 111.70(a)21 CFR 111.55321 CFR 111.56021 CFR 111.260(c)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore South Texas Botanicals
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.